|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Dietary approaches following endoscopic retrograde cholangiopancreatography: A survey of selected endoscopists显示文摘AIM: To describe the dietary recommendations of experienced endoscopists for patients who have undergone endoscopic retrograde cholangiopancreatography (ERCP) and the factors that influence these recommendations. METHODS: Selected U.S. endoscopists with ERCP experience were surveyed by e-mail. A questionnaire with three hypothetical ERCP cases of patients at low, medium and high risk for development of post-ERCP pancreatitis (PEP) was shown. For each scenario, respondents were asked to recommend a post-procedure diet and time to first oral intake. Respondents were also asked about the effect of various clinical factors on their recommendations, including risk of PEP.RESULTS: 97/187 selected ASGE members (51.9%) responded. When risk of PEP was either low, medium or high, 53%, 88% and 96% recommended a diet of clear liquids/NPO respectively, and 2%, 5% and 18% recommended delaying first oral intake until the following day. About 88% of respondents gave the same type of diet to patients at high as those with moderate-risk of PEP (P = 0.04). However, 37% and 43% of respondents gave different types of diet to patients at low vs moderate-risk and low-risk vs high-risk of PEP respectively (P < 0.001). No statistically significant associations were found regarding the effect of other clinical factors or respondent demographics.CONCLUSION: Most experienced endoscopists limit diet to NPO/clear liquids after ERCP for patients at high or moderate risk of post-ERCP pancreatitis. About half allow a low-fat or regular diet in patients at low risk. | Lincoln EVVC Ferreira Mark D Topazian William S Harmsen Alan R Zinsmeister Todd H Baron | 2010 | World Journal of Gastrointestinal Endoscopy2010，2，12： | 3 |
| 2 | Differences in Clinical Profile and Relapse Rate of Type 1 Versus Type 2 Autoimmune Pancreatitis显示文摘 | Raghuwansh P. Sah Suresh T. Chari Rahul Pannala Aravind Sugumar Jonathan E. Clain Michael J. Levy Randall K. Pearson Thomas C. Smyrk Bret T. Petersen Mark D. Topazian Naoki Takahashi Michael B. Farnell Santhi S. Vege | 2010 | Gastroenterology2010，，1： | 3 |
| 3 | Histologic and Imaging Features of Mural Nodules in Mucinous Pancreatic Cysts显示文摘 | Ning Zhong Lizhi Zhang Naoki Takahashi Vladislav Shalmiyev Marcia Irene Canto Jonathan E. Clain John C. Deutsch John DeWitt Mohamad A. Eloubeidi Ferga C. Gleeson Michael J. Levy Shawn Mallery Massimo Raimondo Elizabeth Rajan Tyler Stevens Mark Topazian | 2012 | Clinical Gastroenterology and Hepatology2012，，2： | 2 |
| 4 | Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience显示文摘 | Phil A Hart Mark D Topazian Thomas E Witzig Jonathan E Clain Ferga C Gleeson Robin R Klebig Michael J Levy Randall K Pearson Bret T Petersen Thomas C Smyrk Aravind Sugumar Naoki Takahashi Santhi S Vege Suresh T Chari | 2013 | Gut2013，，11： | 2 |
| 5 | Mutant TP53 in Duodenal Samples of Pancreatic Juice From Patients With Pancreatic Cancer or High-Grade Dysplasia显示文摘 | Mitsuro Kanda Yoshihiko Sadakari Michael Borges Mark Topazian James Farrell Sapna Syngal Jeffrey Lee Ihab Kamel Anne Marie Lennon Spencer Knight Sho Fujiwara Ralph H. Hruban Marcia Irene Canto Michael Goggins | 2013 | Clinical Gastroenterology and Hepatology2013，，6： | 2 |
| 6 | Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience显示文摘 | Phil A Hart Mark D Topazian Thomas E Witzig Jonathan E Clain Ferga C Gleeson Robin R Klebig Michael J Levy Randall K Pearson Bret T Petersen Thomas C Smyrk Aravind Sugumar Naoki Takahashi Santhi S Vege Suresh T Chari | 2013 | Gut2013，，11： | 2 |
| 7 | Percutaneous transluminal angioplasty balloons for endoscopic ultrasound-guided pancreatic duct interventions显示文摘BACKGROUND Endoscopic ultrasound(EUS)-guided main pancreatic duct(PD)access may be used when conventional endoscopic retrograde cholangiopancreatography(ERCP)techniques fail.The use of a percutaneous transluminal angioplasty balloon(PTAB),originally developed for vascular interventions,can be used to facilitate transmural(e.g.,transgastric)PD access and to dilate high-grade pancreatic strictures.AIM To describe the technique,efficacy,and safety of PTABs for EUS-guided PD interventions.METHODS Patients who underwent EUS with use of a PTAB from March 2011 to August 2021 were retrospectively identified from a tertiary care medical center supply database.PTABs included 3-4 French angioplasty catheters with 3-4 mm balloons designed to use over a 0.018-inch guidewire.The primary outcome was technical success.Secondary outcomes included incidence of adverse events(AEs)and need for early reintervention.RESULTS A total of 23 patients were identified(48%female,mean age 55.8 years).Chronic pancreatitis was the underlying etiology in 13(56.5%)patients,surgically altered anatomy(SAA)with stricture in 7(30.4%),and SAA with post-operative leak in 3(13.0%).Technical success was achieved in 20(87%)cases.Overall AE rate was 26%(n=6).All AEs were mild and included 1 pancreatic duct leak,2 cases of post-procedure pancreatitis,and 3 admissions for post-procedural pain.No patients required early re-intervention.CONCLUSION EUS-guided use of PTABs for PD access and/or stricture management is feasible with an acceptable safety profile and can be considered in patients when conventional ERCP cannulation fails. | Jad P AbiMansour Barham K Abu Dayyeh Michael J Levy Andrew C Storm John A Martin Bret T Petersen Ryan J Law Mark D Topazian Vinay Chandrasekhara | 2022 | World Journal of Gastrointestinal Endoscopy2022，14，8： | 2 |
| 8 | Frequent Detection of Pancreatic Lesions in Asymptomatic High-Risk Individuals显示文摘 | Marcia Irene Canto Ralph H. Hruban Elliot K. Fishman Ihab R. Kamel Richard Schulick Zhe Zhang Mark Topazian Naoki Takahashi Joel Fletcher Gloria Petersen Alison P. Klein Jennifer Axilbund Constance Griffin Sapna Syngal John R. Saltzman Koenraad J. Mortele | 2012 | Gastroenterology2012，，4： | 2 |
| 9 | End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients显示文摘AIM To determine if end-stage renal disease (ESRD) is a risk factor for post endoscopic retrograde cholangio-pancreatography (ERCP) adverse events (AEs). METHODS We performed a retrospective cohort study using the Nationwide Inpatient Sample (NIS) 2011-2013. We identified adult patients who underwent ERCP using the International Classification of Diseases 9^(th) Revision (ICD-9-CM). Included patients were divided into three groups: ESRD, chronic kidney disease (CKD), and control. The primary outcome was post-ERCP AEs including pancreatitis, bleeding, and perforation determined based on specific ICD-9-CM codes. Secondary outcomes were length of hospital stay, in-hospital mortality, and admission cost. AEs and mortality were compared using multivariate logistic regression analysis.RESULTS There were 492175 discharges that underwent ERCP during the 3 years. The ESRD and CKD groups contained 7347 and 39403 hospitalizations respectively, whereas the control group had 445424 hospitalizations. Post-ERCP pancreatitis (PEP) was significantly higher in the ESRD group (8.3%) compared to the control group (4.6%) with adjusted odd ratio (aOR) = 1.7 (95% CI: 1.4-2.1, ~aP < 0.001). ESRD was associated with significantly higher ERCP-related bleeding (5.1%) compared to the control group 1.5% (aOR = 1.86, 95%CI: 1.4-2.4, ~aP < 0.001). ESRD had increased hospital mortality 7.1% vs 1.15% in the control OR = 6.6 (95%CI: 5.3-8.2, ~aP < 0.001), longer hospital stay with adjusted mean difference (aMD) = 5.9 d (95% CI: 5.0-6.7 d, ~aP < 0.001) and higher hospitalization charges aMD = $+82064 (95%CI: $68221-$95906, ~aP < 0.001). CONCLUSION ESRD is a risk factor for post-ERCP AEs and is associated with higher hospital mortality. Careful selection and close monitoring is warranted to improve outcomes. | Tarek Sawas Fateh Bazerbachi Samir Haffar Won K Cho Michael J Levy John A Martin Bret T Petersen Mark D Topazian Vinay Chandrasekhara Barham K Abu Dayyeh | 2018 | World Journal of Gastroenterology2018，24，41： | 2 |
| 10 | EUS-guided biliary drainage for patients with malignant biliary obstruction with an indwelling duodenal stent (with videos)显示文摘 | Mouen A. Khashab Larissa L. Fujii Todd H. Baron Marcia Irene Canto Christopher J. Gostout Bret T. Petersen Patrick I. Okolo Mark D. Topazian Michael J. Levy | 2012 | Gastrointestinal Endoscopy2012，，1： | 2 |
| 11 | Disconnected pancreatic duct syndrome in severe acute pancreatitis: clinical and imaging characteristics and outcomes in a cohort of 31 cases显示文摘 | Mario Pelaez-Luna Santhi Swaroop Vege Bret T. Petersen Suresh T. Chari Jonathan E. Clain Michael J. Levy Randal K. Pearson Mark D. Topazian Michael B. Farnell Michael L. Kendrick Todd H. Baron | 2008 | Gastrointestinal Endoscopy2008，，1： | 2 |
| 12 | Pancreaticobiliary and duode- nal perforations after periampullary endoscopic proce- dures : diagnosis and management显示文摘 | Fatima J Baron T H Topazian M D Houghton S G Iqbal C W Ott B J | 2007 | Arch Surg2007，142，： | 1 |
| 13 | Improved outcomes for benign disease with limited pancreatic head resection 显示文摘 | Aspelund G Topazian MD Lee JH | 2005 | J Gastrointest Surg2005，9，3： | 1 |
| 14 | Diagnosis of Autoimmune Pancreatitis: The Mayo Clinic Experience显示文摘 | Suresh T. Chari Thomas C. Smyrk Michael J. Levy Mark D. Topazian Naoki Takahashi Lizhi Zhang Jonathan E. Clain Randall K. Pearson Bret T. Petersen Santhi Swaroop Vege Michael B. Farnell | 2006 | Clinical Gastroenterology and Hepatology2006，，8： | 1 |
| 15 | US - guided ethanolablation of insulinomas: a new treatment option 显示文摘 | l^evy MJ Thompson GB Topazian MD et a) | 2012 | GastrointestEndoso2012，，： | 1 |
| 16 | Outcomes of Endoscopic and Percutaneous Drainage of Pancreatic Fluid Collections Arising after Pancreatic Tail Resection显示文摘 | Nabeel Azeem Todd H. Baron Mark D. Topazian Ning Zhong Chad J. Fleming Michael L. Kendrick | 2012 | Journal of the American College of Surgeons2012，，2： | 1 |
| 17 | Pancreat- icobiliary and duodenal perforations after periampullary endo- scopic procedures: diagnosis and management 显示文摘 | FATIMA J BARON T H TOPAZIAN M D | 2007 | Arch Surg2007，142，5： | 1 |
| 18 | EUS-guided trucut biopsy in establishing autoimmune pancreatitis as the cause of obstructive jaundice显示文摘 | Michael J. Levy Raghuram P. Reddy Maurits J. Wiersema Thomas C. Smyrk Jonathan E. Clain Gavin C. Harewood Randall K. Pearson Elizabeth Rajan Mark D. Topazian Tony E. Yusuf Suresh T. Chari Bret T. Petersen | 2005 | Gastrointestinal Endoscopy2005，，3： | 1 |
| 19 | Pancreatic head excavation: a variation on the theme of duodenum-preserving pancreatic head resection 显示文摘 | Andersen DK Topazian MD | 2004 | Arch Surg2004，139，4： | 1 |
| 20 | Endoscopic ultrasound in idiopathic acute panereatitis 显示文摘 | TANDON M TOPAZIAN M | 2001 | Am J Gastroenterol2001，96，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员